Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study

• 主要な著者: Chen B (著者), Zhang L (著者), Cheng J (著者), Wu T (著者), Lei J (著者), Yang X (著者), Zhang R (著者), Safadi R (著者), Li Y (著者), Si T (著者), Lu Y (著者)
• フォーマット: 図書
• 出版事項: Dove Medical Press, 2022-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Bowen Chen,1,2,* Linzhi Zhang,2,3,* Jiamin Cheng,2,* Tong Wu,2 Jin Lei,2,4 Xu Yang,5 Rongling Zhang,6 Rifaat Safadi,7 Yinyin Li,2 Tongguo Si,3 Yinying Lu1,2,8,9 1Peking University 302 Clinical Medical School, Beijing, People's Republic of China; 2Senior Department of Hep...